ES2033512T3 - Composicion antiastenica, su procedimiento de preparacion y su utilizacion. - Google Patents

Composicion antiastenica, su procedimiento de preparacion y su utilizacion.

Info

Publication number
ES2033512T3
ES2033512T3 ES198989200280T ES89200280T ES2033512T3 ES 2033512 T3 ES2033512 T3 ES 2033512T3 ES 198989200280 T ES198989200280 T ES 198989200280T ES 89200280 T ES89200280 T ES 89200280T ES 2033512 T3 ES2033512 T3 ES 2033512T3
Authority
ES
Spain
Prior art keywords
asthenic
composition
preparation procedure
ginseng
acetylasparaginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES198989200280T
Other languages
English (en)
Inventor
Joseph Geczy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
(r)therabel Research Sa/nv(r)
Original Assignee
(r)therabel Research Sa/nv(r)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (r)therabel Research Sa/nv(r) filed Critical (r)therabel Research Sa/nv(r)
Application granted granted Critical
Publication of ES2033512T3 publication Critical patent/ES2033512T3/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

COMPOSICION ANTIASTENICA QUE COMPRENDE COMO INGREDIENTE ACTIVO UNA MEZCLA DE GINSENG Y DE N-ACETILASPORAGINATO DE ARGININA, EN ASOCIACION CON UN EXCIPIENTE FAMACOLOGICAMENTE ACEPTABLE, LA PROPORCION EN PESO DE GINSENG RESPECTO AL N-ACETILASPORAGINATO DE ARGININA ES DEL ORDEN DE 1/1 O 1/5, SEGUN QUE EL GINSENG SE ENCUENTRE EN FORMA DE POLVO O EXTRACTO.
ES198989200280T 1988-02-25 1989-02-07 Composicion antiastenica, su procedimiento de preparacion y su utilizacion. Expired - Fee Related ES2033512T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE8800222A BE1001465A3 (fr) 1988-02-25 1988-02-25 Composition antiasthenique, son procede de preparation et son utilisation.

Publications (1)

Publication Number Publication Date
ES2033512T3 true ES2033512T3 (es) 1993-03-16

Family

ID=3883282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989200280T Expired - Fee Related ES2033512T3 (es) 1988-02-25 1989-02-07 Composicion antiastenica, su procedimiento de preparacion y su utilizacion.

Country Status (6)

Country Link
EP (1) EP0334402B1 (es)
AT (1) ATE71531T1 (es)
BE (1) BE1001465A3 (es)
DE (1) DE68900695D1 (es)
ES (1) ES2033512T3 (es)
GR (1) GR3003678T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671488A1 (fr) * 1991-01-10 1992-07-17 Bilicz Richard Composition pharmaceutique ou dietetique indiquee pour ses proprietes anti-stress, anti-fatigue, anti-vieillissement.
DE19756677A1 (de) * 1997-12-19 1999-06-24 Krewel Meuselbach Gmbh Arzneipflanzentrockenextrakte

Also Published As

Publication number Publication date
ATE71531T1 (de) 1992-02-15
GR3003678T3 (es) 1993-03-16
BE1001465A3 (fr) 1989-11-07
EP0334402A1 (fr) 1989-09-27
DE68900695D1 (de) 1992-02-27
EP0334402B1 (fr) 1992-01-15

Similar Documents

Publication Publication Date Title
DE69418252D1 (de) Stabilisierte, feste pharmazeutische Zubereitung, die Dextromethorphan Phenylpropanolamine und Coffein enthält
NO870181L (no) Fremgangsmaate for fremstilling av et fast farmasoeytisk preparat med forsinket frigjoering.
CA2058428A1 (en) Analgesic formulations
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
DK503687D0 (da) Farmaceutisk praeparat af ibuprofen
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
CA2063273A1 (en) Surfactant compositions and methods
ITMI920710A0 (it) Siringa di sicurezza con ago retrattile dopo l'uso in modo da evitare il riutilizzo della siringa e la diffusione di malattie contagiose per punture accidentali dell'ago.
GR3002765T3 (en) New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient
ES2033512T3 (es) Composicion antiastenica, su procedimiento de preparacion y su utilizacion.
PH27567A (en) Topical compositions
JPS5781409A (en) External plaster
ZA894422B (en) Pyrrole derivatives,their preparation and their use as pharmaceutical active compounds
AR229875A1 (es) Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos
DE2860691D1 (en) 1,2,4-oxadiazol derivatives, their preparation and application in pharmaceutical compositions
JPS6456622A (en) Percutaneous absorbefacient base composition
SE8704240D0 (sv) Analgesic preparations
JPS5436255A (en) Novel sesquiterpene analogue, its preparation, and pharmatheutical containing the same
EP0355899A3 (en) Nucleotide derivatives
GB2008947A (en) Compositions containing microfibres
WO1997040844A3 (en) Anti-hiv activity of medicinal plant extract preparation
DE3062168D1 (en) Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
AU5744890A (en) Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 334402

Country of ref document: ES

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20011110